ALNY - Alnylam wins FDA panel backing additional Onpattro indications
2023-09-13 17:00:37 ET
More on Alnylam Pharmaceuticals
- Alnylam Continues To Deliver, But An Upcoming FDA Meeting Could Create Some Volatility
- Alnylam: Unlimited Promise Or Unlimited Losses?
- Alnylam succeeds in Phase 2 trial for blood pressure drug
- Seeking Alpha’s Quant Rating on Alnylam Pharmaceuticals
For further details see:
Alnylam wins FDA panel backing additional Onpattro indications